Bursa Announcements
Stock Name / Code :
DPHARMA ( 7148 )
Year :
2026
2025
2024
2023
2022
Archives
Select Date Range :
Categories :
Category
Additional Listing Announcement
Annual Audited Accounts
Annual Reports
Change of Corporate Information
Changes in Shareholdings
Circulars/Notice to Shareholders
Dealings in Listed Securities (Chapter 14 of Listing Requirements)
Delisting of Securities
Disclosure On Quarterly Production
Entitlements
Expiry / Maturity / Termination of Securities
Financial Results
General Announcement
General Meetings
Important Relevant Dates for Renounceable Rights
Investor Alert
IPO Announcement/LEAP Market Announcement
Listing Circulars
Listing Information and Profile
Prospectus
Reply to Query
Shares Buy Back
Special Announcements
Take-over Offer
Transfer of Listing
Unusual Market Activity
Filter
Reset
Thursday - 19 Feb 2026
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
Monday - 16 Feb 2026
OTHERS
ACCEPTANCE OF TENDER OFFER (HEREINAFTER REFERRED TO AS THE "LETTER OF AWARD" OR "LOA") FOR THE SUPPLY OF RECOMBINANT HUMAN INSULIN FORMULATIONS (HEREINAFTER REFERRED TO AS THE "PRODUCTS") TO THE GOVERNMENT OF MALAYSIA
OTHERS
ACCEPTANCE OF TENDER OFFER (HEREINAFTER REFERRED TO AS THE "LETTER OF AWARD" OR "LOA") FOR THE SUPPLY OF INSULIN INJECTION (HEREINAFTER REFERRED TO AS THE "PRODUCT") BY DUOPHARMA (M) SENDIRIAN BERHAD (A WHOLLY-OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD) TO THE MINISTRY OF HEALTH'S FACILITIES
Friday - 13 Feb 2026
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
Wednesday - 11 Feb 2026
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
Thursday - 5 Feb 2026
MATERIAL LITIGATION
KUALA LUMPUR HIGH COURT CIVIL SUIT NO. WA-22IP-15-02/2025 - WRIT OF SUMMONS AND STATEMENT OF CLAIM SERVED ON DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. (A WHOLLY-OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD) BY SUN PHARMACEUTICAL INDUSTRIES LIMITED
Tuesday - 3 Feb 2026
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
MATERIAL LITIGATION
KUALA LUMPUR HIGH COURT CIVIL SUIT NO. WA-22IP-15-02/2025 - WRIT OF SUMMONS AND STATEMENT OF CLAIM SERVED ON DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. (A WHOLLY-OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD) BY SUN PHARMACEUTICAL INDUSTRIES LIMITED
Thursday - 29 Jan 2026
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
Monday - 22 Dec 2025
MATERIAL LITIGATION
KUALA LUMPUR HIGH COURT CIVIL SUIT NO. WA-22IP-15-02/2025 - WRIT OF SUMMONS AND STATEMENT OF CLAIM SERVED ON DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. (A WHOLLY-OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD) BY SUN PHARMACEUTICAL INDUSTRIES LIMITED
Friday - 28 Nov 2025
Change in Boardroom - ENCIK LEONARD ARIFF BIN ABDUL SHATAR
Change in Principal Officer - MR CHEK WU KONG
Change in Principal Officer - PUAN ROHAYU ROSNANI BINTI MOHD ADANAN
Change in Principal Officer - ENCIK WAN AMIR-JEFFERY BIN WAN ABDUL MAJID
Change in Principal Officer - ENCIK LEONARD ARIFF BIN ABDUL SHATAR
«
1
2
3
4
5
6
7
8
9
10
»